Chongrui Xu
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Efficacy and toxicity of maintenance therapy with PD-1/PD-L1 inhibitors plus pemetrexed vs . immunotherapy alone for stage III/IV non-squamous non-small cell lung cancer: A real-world study.
Journal: Chinese medical journal
Published: September 29, 2025
Letter Regarding "Revolutionizing NSCLC Treatment: Unleashing the Potential of IBI351 and Its Critical Care Impact".
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 27, 2024
Efficacy and Safety of KRASG12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 28, 2024
Circulating tumor DNA (ctDNA)-based minimal residual disease in non-small cell lung cancer.
Journal: Chinese medical journal pulmonary and critical care medicine
Published: November 06, 2022
Organ-specific efficacy in advanced non-small cell lung cancer patients treated with first-line single-agent immune checkpoint inhibitors.
Journal: Chinese medical journal
Published: July 23, 2022
Phase I/Ib dose-escalation study of avelumab in Chinese patients with advanced solid tumors.
Journal: Future oncology (London, England)
Published: March 31, 2022
HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers.
Journal: Cancer discovery
Published: February 24, 2020
Effects of epidermal growth factor receptor-tyrosine kinase inhibitors alone on EGFR-mutant non-small cell lung cancer with brain metastasis.
Journal: Thoracic cancer
Published: April 30, 2016
Efficacies of gefitinib versus paclitaxel/carboplatin for patients with advanced pulmonary adenocarcinoma
Journal: Zhonghua yi xue za zhi
Published: November 18, 2014
Can EGFR-TKIs be used in first line treatment for advanced non-small cell lung cancer based on selection according to clinical factors? - A literature-based meta-analysis.
Journal: Journal of hematology & oncology
Published: May 01, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026